HEPATITIS B
Clinical trials for HEPATITIS B explained in plain language.
Never miss a new study
Get alerted when new HEPATITIS B trials appear
Sign up with your email to follow new studies for HEPATITIS B, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Which hepatitis b pill is safer for kidneys? new trial aims to find out
Disease control Recruiting nowThis study compares two common antiviral drugs, tenofovir alafenamide (TAF) and entecavir (ETV), in adults with chronic hepatitis B. The goal is to see which one better controls the virus and protects kidney function. About 140 participants will be randomly assigned to one of the…
Matched conditions: HEPATITIS B
Phase: PHASE4 • Sponsor: Taichung Veterans General Hospital • Aim: Disease control
Last updated May 16, 2026 23:50 UTC
-
Can a prevention vaccine help fight chronic hepatitis b? new trial aims to find out
Disease control Recruiting nowThis early-stage study is testing whether HEPLISAV-B, a vaccine normally used to prevent hepatitis B, is safe for people who already have chronic hepatitis B. Ten adults on antiviral therapy will receive two vaccine shots and be monitored for side effects and immune responses ove…
Matched conditions: HEPATITIS B
Phase: PHASE1 • Sponsor: University of Maryland, Baltimore • Aim: Disease control
Last updated May 14, 2026 12:06 UTC
-
Could stem cells help repair livers damaged by hepatitis b?
Disease control Recruiting nowThis early-stage study is testing whether stem cells from donated umbilical cords are safe for people with advanced liver scarring (cirrhosis) caused by hepatitis B. About 20 adults aged 18-60 with moderate to severe liver disease will receive the stem cell treatment. The main go…
Matched conditions: HEPATITIS B
Phase: PHASE1 • Sponsor: Sclnow Biotechnology Co., Ltd. • Aim: Disease control
Last updated May 14, 2026 12:05 UTC
-
New antibody shot aims to tame chronic hepatitis b
Disease control Recruiting nowThis early-stage study tests a single dose of a lab-made antibody (HepB mAb19) in 37 adults with chronic hepatitis B who are already on standard antiviral pills. The main goal is to check safety and how the body processes the antibody, not to cure the infection. Participants will…
Matched conditions: HEPATITIS B
Phase: PHASE1 • Sponsor: Rockefeller University • Aim: Disease control
Last updated May 13, 2026 16:02 UTC
-
A drop of blood could detect hidden viruses in drug users
Diagnosis Recruiting nowThis study is testing whether a dried blood spot test can effectively screen for hepatitis B, hepatitis C, and AIDS in people who use drugs. The goal is to make testing easier and more accessible for this group. About 500 current or former drug users will take part.
Matched conditions: HEPATITIS B
Phase: NA • Sponsor: University Hospital, Rouen • Aim: Diagnosis
Last updated May 11, 2026 20:48 UTC
-
New trial aims to catch liver cancer earlier in thousands at risk
Prevention Recruiting nowThis study tests whether a blood test (GALAD) is better than ultrasound for finding liver cancer early in 5500 people with cirrhosis or chronic hepatitis B. Participants will be randomly assigned to one of two screening methods every six months. The goal is to see which approach …
Matched conditions: HEPATITIS B
Phase: PHASE4 • Sponsor: University of Texas Southwestern Medical Center • Aim: Prevention
Last updated May 14, 2026 12:02 UTC
-
Zambia launches decade-long liver health watch for hepatitis b and HIV patients
Knowledge-focused Recruiting nowThis study follows 390 adults in Zambia with hepatitis B, some also with HIV, for several years. Researchers track how the liver and immune system change over time, especially when standard antiviral treatments are started. The goal is to better understand the disease, not to tes…
Matched conditions: HEPATITIS B
Sponsor: University of Alabama at Birmingham • Aim: Knowledge-focused
Last updated May 16, 2026 23:37 UTC
-
15,000 Patients' records analyzed to uncover liver disease links
Knowledge-focused Recruiting nowThis study looks at medical records from 15,000 people with chronic liver diseases (like hepatitis, fatty liver, or cirrhosis) to understand how these conditions affect other body systems. Researchers will track new cases of liver cancer and serious liver complications over time.…
Matched conditions: HEPATITIS B
Sponsor: Taipei Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation • Aim: Knowledge-focused
Last updated May 13, 2026 15:58 UTC
-
Kidney health may change how hepatitis b drug works
Knowledge-focused Recruiting nowThis study looks at how the body handles a single dose of bepirovirsen, a drug for hepatitis B, in people with different levels of kidney function. About 32 adults with severe or moderate kidney disease and healthy volunteers will take part. The goal is to see if kidney problems …
Matched conditions: HEPATITIS B
Phase: PHASE1 • Sponsor: GlaxoSmithKline • Aim: Knowledge-focused
Last updated May 11, 2026 20:52 UTC
-
Massive liver study seeks 8,000 volunteers to unlock disease secrets
Knowledge-focused Recruiting nowThis study follows people with or at risk for liver diseases (like hepatitis B, C, D) to learn how these conditions develop and progress. Participants give blood and urine samples, get yearly liver ultrasounds, and may have optional biopsies. The goal is to gather information, no…
Matched conditions: HEPATITIS B
Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) • Aim: Knowledge-focused
Last updated May 08, 2026 12:02 UTC